IBS, Spjotgard drive adoption of fingerprint drug testing across Scandinavia

Intelligent Bio Solutions (INBS), IBS, announced the success of its ongoing partnership with Spjotgard. The collaboration is accelerating the adoption of the Intelligent Fingerprinting Drug Screening System across Sweden, Norway, and Denmark, with a growing interest in Finland. “From the very beginning, we’ve seen strong interest in fingerprint-based testing across the region,” said Hans Svensson, joint owner of Spjotgard. “Traditional methods like saliva and urine are still common, but our customers, especially in workplace safety and education, are seeking more hygienic, easy to use and less invasive alternatives. Fingerprint drug testing delivers that while delivering comparable levels of accuracy, saving time and reducing disruption.”